APA (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM-5). American Psychiatric Publishing: Arlington, VA.
Belbasis, L, Bellou, V, Evangelou, E, Ioannidis, JP, Tzoulaki, I (2015). Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurology
Berk, M, Kapczinski, F, Andreazza, AC, Dean, OM, Giorlando, F, Maes, M, Yucel, M, Gama, CS, Dodd, S, Dean, B, Magalhaes, PV, Amminger, P, McGorry, P, Malhi, GS (2011). Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience and Biobehavioral Reviews
Birmaher, B, Gill, MK, Axelson, DA, Goldstein, BI, Goldstein, TR, Yu, H, Liao, F, Iyengar, S, Diler, RS, Strober, M, Hower, H, Yen, S, Hunt, J, Merranko, JA, Ryan, ND, Keller, MB (2014). Longitudinal trajectories and associated baseline predictors in youths with bipolar spectrum disorders. American Journal of Psychiatry
Brown, NC, Andreazza, AC, Young, LT (2014). An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Research
Button, KS, Ioannidis, JP, Mokrysz, C, Nosek, BA, Flint, J, Robinson, ES, Munafo, MR (2013). Power failure: why small sample size undermines the reliability of neuroscience. Nature Reviews Neuroscience
Cuijpers, P, Smit, F, Bohlmeijer, E, Hollon, SD, Andersson, G (2010). Efficacy of cognitive-behavioural therapy and other psychological treatments for adult depression: meta-analytic study of publication bias. British Journal of Psychiatry
Cuthbert, BN (2014). The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry
Dargel, AA, Godin, O, Kapczinski, F, Kupfer, DJ, Leboyer, M (2015). C-reactive protein alterations in bipolar disorder: a meta-analysis. Journal of Clinical Psychiatry
Davis, J, Maes, M, Andreazza, A, McGrath, JJ, Tye, SJ, Berk, M (2015). Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass. Molecular Psychiatry
Diniz, BS, Sibille, E, Ding, Y, Tseng, G, Aizenstein, HJ, Lotrich, F, Becker, JT, Lopez, OL, Lotze, MT, Klunk, WE, Reynolds, CF, Butters, MA (2015). Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression. Molecular Psychiatry
Dupont, WD, Plummer, WD Jr. (1990). Power and sample size calculations. A review and computer program. Controlled Clinical Trials
Egger, M, Davey Smith, G, Schneider, M, Minder, C (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal
Fava, GA (2014). Road to nowhere. World Psychiatry
Fava, GA, Guidi, J, Grandi, S, Hasler, G (2014). The missing link between clinical states and biomarkers in mental disorders. Psychotherapy and Psychosomatics
Fernandes, BS, Gama, CS, Cereser, KM, Yatham, LN, Fries, GR, Colpo, G, de Lucena, D, Kunz, M, Gomes, FA, Kapczinski, F (2011). Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. Journal of Psychiatric Research
Fernandes, BS, Steiner, J, Berk, M, Molendijk, ML, Gonzalez-Pinto, A, Turck, CW, Nardin, P, Goncalves, CA (2015). Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications. Molecular Psychiatry
First, MB (2014). Preserving the clinician-researcher interface in the age of RDoC: the continuing need for DSM-5/ICD-11 characterization of study populations. World Psychiatry
Flint, J, Cuijpers, P, Horder, J, Koole, SL, Munafo, MR (2015). Is there an excess of significant findings in published studies of psychotherapy for depression?
Frey, BN, Andreazza, AC, Houenou, J, Jamain, S, Goldstein, BI, Frye, MA, Leboyer, M, Berk, M, Malhi, GS, Lopez-Jaramillo, C, Taylor, VH, Dodd, S, Frangou, S, Hall, GB, Fernandes, BS, Kauer-Sant'Anna, M, Yatham, LN, Kapczinski, F, Young, LT (2013). Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Australian and New Zealand Journal of Psychiatry
Fusar-Poli, P, Radua, J, Frascarelli, M, Mechelli, A, Borgwardt, S, Di Fabio, F, Biondi, M, Ioannidis, JP, David, SP (2014). Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders. Human Brain Mapping
Girshkin, L, Matheson, SL, Shepherd, AM, Green, MJ (2014). Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis. Psychoneuroendocrinology
Goldstein, BI, Young, LT (2013). Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function. Current Psychiatry Reports
Higgins, J, Green, S (2013). Cochrane Handbook for systematic reviews of interventions, version 5.0. 2 (updated September 2009). The Cochrane Collaboration, 2009 (http://www.cochrane-handbook.org/). Accessed 18 August 2014.
Higgins, JP (2008). Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. International Journal of Epidemiology
Higgins, JP, Thompson, SG (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine
Higgins, JP, Thompson, SG, Spiegelhalter, DJ (2009). A re-evaluation of random-effects meta-analysis. Journal of the Royal Statistical Society. Series A (Statistics in Society)
Huedo-Medina, TB, Sánchez-Meca, J, Marin-Martinez, F, Botella, J (2006). Assessing heterogeneity in meta-analysis: Q statistic or I2 index?
Insel, TR, Landis, SC (2013). Twenty-five years of progress: the view from NIMH and NINDS. Neuron
Ioannidis, JP (2005). Why most published research findings are false. PLoS Medicine
Ioannidis, JP (2013). Clarifications on the application and interpretation of the test for excess significance and its extensions. Journal of Mathematical Psychology
Ioannidis, JP, Panagiotou, OA (2011). Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses. Journal of the American Medical Association
Ioannidis, JP, Tarone, R, McLaughlin, JK (2011). The false-positive to false-negative ratio in epidemiologic studies. Epidemiology
Ioannidis, JP, Trikalinos, TA (2007). An exploratory test for an excess of significant findings. Clinical Trials (London, England)
Janelidze, S, Ventorp, F, Erhardt, S, Hansson, O, Minthon, L, Flax, J, Samuelsson, M, Traskman-Bendz, L, Brundin, L (2013). Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters. Psychoneuroendocrinology
Kapur, S, Phillips, AG, Insel, TR (2012). Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?
Lin, PY (2009). State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: a meta-analytic study. Neuroscience Letters
Looney, SW, el-Mallakh, RS (1997). Meta-analysis of erythrocyte Na,K-ATPase activity in bipolar illness. Depression and Anxiety
McGorry, P, Keshavan, M, Goldstone, S, Amminger, P, Allott, K, Berk, M, Lavoie, S, Pantelis, C, Yung, A, Wood, S, Hickie, I (2014). Biomarkers and clinical staging in psychiatry. World Psychiatry
Modabbernia, A, Taslimi, S, Brietzke, E, Ashrafi, M (2013). Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biological Psychiatry
Moher, D, Liberati, A, Tetzlaff, J, Altman, DG (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of Clinical Epidemiology
Munkholm, K, Brauner, JV, Kessing, LV, Vinberg, M (2013
a). Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. Journal of Psychiatric Research
Munkholm, K, Vinberg, M, Vedel Kessing, L (2013
b). Cytokines in bipolar disorder: a systematic review and meta-analysis. Journal of Affective Disorders
Murck, H, Laughren, T, Lamers, F, Picard, R, Walther, S, Goff, D, Sainati, S (2015). Taking personalized medicine seriously: biomarker approaches in phase IIb/III studies in major depression and schizophrenia. Innovations in Clinical Neuroscience
Parnas, J (2014). The RDoC program: psychiatry without psyche?
Phillips, ML, Chase, HW, Sheline, YI, Etkin, A, Almeida, JR, Deckersbach, T, Trivedi, MH (2015). Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches. American Journal of Psychiatry
Polyakova, M, Stuke, K, Schuemberg, K, Mueller, K, Schoenknecht, P, Schroeter, ML (2015). BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis. Journal of Affective Disorders
Rosa, AR, Singh, N, Whitaker, E, de Brito, M, Lewis, AM, Vieta, E, Churchill, GC, Geddes, JR, Goodwin, GM (2014). Altered plasma glutathione levels in bipolar disorder indicates higher oxidative stress; a possible risk factor for illness onset despite normal brain-derived neurotrophic factor (BDNF) levels. Psychological Medicine
Scola, G, Andreazza, AC (2014). Current state of biomarkers in bipolar disorder. Current Psychiatry Reports
Sistrom, CL, Mergo, PJ (2000). A simple method for obtaining original data from published graphs and plots. American Journal of Roentgenology
Teixeira, AL, Barbosa, IG, Machado-Vieira, R, Rizzo, LB, Wieck, A, Bauer, ME (2013). Novel biomarkers for bipolar disorder. Expert Opinion on Medical Diagnostics
Tsilidis, KK, Papatheodorou, SI, Evangelou, E, Ioannidis, JP (2012). Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk. Journal of the National Cancer Institute
Tzoulaki, I, Siontis, KC, Evangelou, E, Ioannidis, JP (2013). Bias in associations of emerging biomarkers with cardiovascular disease. JAMA Internal Medicine
Vieta, E (2014). The bipolar maze: a roadmap through translational psychopathology. Acta Psychiatrica Scandinavica
WHO (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization: Geneva.
Young, SS, Bang, H (2004). The file-drawer problem, revisited. Science
306, 1133–1134; author reply 1133–1134.